Celia Witten

570 total citations
11 papers, 378 citations indexed

About

Celia Witten is a scholar working on Physiology, Molecular Biology and Biomedical Engineering. According to data from OpenAlex, Celia Witten has authored 11 papers receiving a total of 378 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Physiology, 3 papers in Molecular Biology and 3 papers in Biomedical Engineering. Recurrent topics in Celia Witten's work include Biomedical Ethics and Regulation (5 papers), Pluripotent Stem Cells Research (3 papers) and Biomedical and Engineering Education (2 papers). Celia Witten is often cited by papers focused on Biomedical Ethics and Regulation (5 papers), Pluripotent Stem Cells Research (3 papers) and Biomedical and Engineering Education (2 papers). Celia Witten collaborates with scholars based in United States, United Kingdom and Thailand. Celia Witten's co-authors include Peter Marks, Robert M. Califf, Michael D. Roberts, Stephanie L. Simek, Richard McFarland, Carlos Peña, Michael Schlosser, Patrick Au, Deborah A. Hursh and B Schneider and has published in prestigious journals such as New England Journal of Medicine, Stroke and The American Journal of Sports Medicine.

In The Last Decade

Celia Witten

11 papers receiving 361 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Celia Witten United States	8	128	100	83	67	66	11	378
Ludovico Magaudda Italy	15	101 0.8×	158 1.6×	42 0.5×	55 0.8×	31 0.5×	38	608
Sameer S. Jejurikar United States	11	267 2.1×	170 1.7×	115 1.4×	92 1.4×	49 0.7×	14	529
Yinglu Guo China	7	120 0.9×	178 1.8×	59 0.7×	39 0.6×	221 3.3×	18	447
Izumi Honda Japan	16	255 2.0×	168 1.7×	123 1.5×	51 0.8×	178 2.7×	36	803
Marila Cervio Italy	9	52 0.4×	91 0.9×	25 0.3×	43 0.6×	89 1.3×	19	419
Ingrid Arvidsson Sweden	14	105 0.8×	175 1.8×	38 0.5×	17 0.3×	130 2.0×	24	889
David H. Harter United States	15	82 0.6×	152 1.5×	70 0.8×	75 1.1×	102 1.5×	50	604
E Torchiana Italy	8	281 2.2×	96 1.0×	56 0.7×	29 0.4×	83 1.3×	9	467
Robert T. Shebert United States	9	130 1.0×	93 0.9×	40 0.5×	132 2.0×	40 0.6×	11	543
BA Michel Switzerland	7	83 0.6×	67 0.7×	25 0.3×	26 0.4×	28 0.4×	24	408

Countries citing papers authored by Celia Witten

Since Specialization

Citations

This map shows the geographic impact of Celia Witten's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Celia Witten with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Celia Witten more than expected).

Fields of papers citing papers by Celia Witten

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Celia Witten. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Celia Witten. The network helps show where Celia Witten may publish in the future.

Co-authorship network of co-authors of Celia Witten

This figure shows the co-authorship network connecting the top 25 collaborators of Celia Witten. A scholar is included among the top collaborators of Celia Witten based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Celia Witten. Celia Witten is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

1.

Marks, Peter & Celia Witten. (2020). Toward a new framework for the development of individualized therapies. Gene Therapy. 28(10-11). 615–617. 14 indexed citations

2.

Marks, Peter, Celia Witten, & Robert M. Califf. (2016). Clarifying Stem-Cell Therapy’s Benefits and Risks. New England Journal of Medicine. 376(11). 1007–1009. 193 indexed citations

3.

Witten, Celia, Richard McFarland, & Stephanie L. Simek. (2015). Concise Review: The U.S. Food and Drug Administration and Regenerative Medicine. Stem Cells Translational Medicine. 4(12). 1495–1499. 23 indexed citations

4.

Au, Patrick, Deborah A. Hursh, ‬Hong Ngee Lim, et al.. (2012). FDA Oversight of Cell Therapy Clinical Trials. Science Translational Medicine. 4(149). 149fs31–149fs31. 32 indexed citations

5.

Whittlesey, Kevin J. & Celia Witten. (2012). US FDA Outreach to the Regenerative Medicine Community: Challenges and Opportunities. Regenerative Medicine. 7(4). 595–603. 2 indexed citations

6.

Peña, Carlos, et al.. (2004). The Food and Drug Administration Medical Device Review Process. Stroke. 36(2). 404–406. 34 indexed citations

7.

Witten, Celia, et al.. (1993). Long thoracic nerve palsy in a professional ballet dancer. The American Journal of Sports Medicine. 21(4). 626–628. 19 indexed citations

8.

Witten, Celia, et al.. (1993). A case of cerebral infarction in association with free protein S deficiency and oral contraceptive use.. PubMed. 74(1). 98–100. 3 indexed citations

9.

Roberts, Michael D., et al.. (1992). METHYLPHENIDATE IN STROKE PATIENTS WITH DEPRESSION. American Journal of Physical Medicine & Rehabilitation. 71(4). 239–241. 45 indexed citations

10.

Witten, Celia. (1989). Safe Harbors for Electromyographers. American Journal of Physical Medicine & Rehabilitation. 68(5). 254–255. 1 indexed citations

11.

Witten, Celia. (1989). Pulmonary Toxicity of Nitrofurantoin. Archives of Physical Medicine and Rehabilitation. 70(1). 55–57. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact